Literature DB >> 15641136

Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically.

Yoshinori Horie1, Jing-Yan Han, Shuka Mori, Masahiro Konishi, Mikio Kajihara, Takehiko Kaneko, Yoshiyuki Yamagishi, Shinzo Kato, Hiromasa Ishii, Toshifumi Hibi.   

Abstract

AIM: Cardiotonic Pill (CP), an oral herbal medicine that includes Danshen (Salviae Miltiorrhizae), Panax notoginseny and Dyroblanops aromatica gaertn, has been clinically used for vascular diseases such as occlusive vasculitis, coronary diseases, atherosclerosis, and cerebral infarction. The main component, Salviae Miltiorrhizae, has been reported to prevent cerebral and intestinal reperfusion injury. However, little is known about the effect of CP on hepatic microcirculation. Thus, this study aimed to determine whether CP could affect hepatic microvascular dysfunction elicited by gut ischemia/reperfusion (I/R) in rats fed ethanol chronically.
METHODS: Male Wistar rats were pair-fed with a liquid diet containing ethanol or isocaloric control diet for 6 wk. After laparotomy, one lobe of the liver was examined through an inverted intravital microscope. The rats were exposed to 30 min of gut ischemia followed by 60 min of reperfusion. Rhodamine-6G-labeled leukocytes in the sinusoids were observed 90 min after the onset of superior mesenteric artery occlusion. Plasma tumor necrosis factor (TNF)-alpha and endotoxin levels were measured 1 h after the onset of reperfusion. Plasma alanine aminotransferase (ALT) activities were measured 6 h after the onset of reperfusion. In another set of experiments, CP (0.8 g/kg, intragastrically) was administered 1 and 24 h before the onset of ischemia.
RESULTS: In control rats, gut I/R elicited increases in the number of stationary leukocytes, and plasma TNF-alpha and endotoxin levels and plasma ALT activities. These changes were mitigated by pretreatment with CP. In ethanol-fed rats, the gut I/R-induced increases in the number of stationary leukocytes, plasma endotoxin levels and ALT activities were enhanced. Pretreatment with CP attenuated the enhancement of gut I/R-induced responses by chronic ethanol consumption.
CONCLUSION: These results suggest that CP prevents the gut I/R-induced hepatic microvascular dysfunction and hepatocellular injury. A reduction of inflammatory responses such as TNF-alpha production via reduction of blood endotoxin levels appears to be involved in the mechanisms. Chronic ethanol consumption enhances gut I/R-induced hepatic microvascular and hepatocellular injury. CP also attenuates an enhancement of gut I/R-induced responses by chronic ethanol consumption via the reduction of blood endotoxin levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641136      PMCID: PMC4250801          DOI: 10.3748/wjg.v11.i4.511

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Analysis of bioactive components in traditional Chinese medicines by molecular biochromatography with alpha1-acid glycoprotein stationary phase.

Authors:  H Wang; H Zou; L Kong; J Ni
Journal:  J Basic Clin Physiol Pharmacol       Date:  2000

2.  Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion.

Authors:  Y Horie; R Wolf; D C Anderson; D N Granger
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease.

Authors:  M Arai; S Nakano; F Okuno; Y Hirano; K Sujita; T Kobayashi; H Ishii; M Tsuchiya
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

4.  Role of endothelin in endotoxin-induced hepatic microvascular dysfunction in rats fed chronically with ethanol.

Authors:  Y Horie; S Kato; E Ohki; H Tamai; H Ishii
Journal:  J Gastroenterol Hepatol       Date:  2001-08       Impact factor: 4.029

5.  Automated kinetic assay for endotoxin and (1-->3)-beta-D-glucan in human blood.

Authors:  H Tamura; Y Arimoto; S Tanaka; M Yoshida; T Obayashi; T Kawai
Journal:  Clin Chim Acta       Date:  1994-04       Impact factor: 3.786

6.  Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats.

Authors:  Y Horie; R Wolf; M Miyasaka; D C Anderson; D N Granger
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

7.  Effect of lipopolysaccharides on erythrocyte flow velocity in rat liver.

Authors:  Y Horie; S Kato; E Ohki; H Hamamatsu; D Fukumura; I Kurose; H Suzuki; M Suematsu; S Miura; H Ishii
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

8.  Effect of chronic ethanol feeding on endotoxin-induced hepatic injury: role of adhesion molecules on leukocytes and hepatic sinusoid.

Authors:  E Ohki; S Kato; H Ohgo; T Mizukami; M Fukuda; H Tamai; Y Okamura; M Matsumoto; H Suzuki; H Yokoyama; H Ishii
Journal:  Alcohol Clin Exp Res       Date:  1998-05       Impact factor: 3.455

9.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.

Authors:  I Kurose; D C Anderson; M Miyasaka; T Tamatani; J C Paulson; R F Todd; J R Rusche; D N Granger
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

10.  Inhibition of TNF-alpha induced cell death in human umbilical vein endothelial cells and Jurkat cells by protocatechuic acid.

Authors:  J Zhou-Stache; R Buettner; G Artmann; C Mittermayer; A K Bosserhoff
Journal:  Med Biol Eng Comput       Date:  2002-11       Impact factor: 2.602

View more
  8 in total

1.  Total salvianolic acid improves ischemia-reperfusion-induced microcirculatory disturbance in rat mesentery.

Authors:  Ming-Xia Wang; Yu-Ying Liu; Bai-He Hu; Xiao-Hong Wei; Xin Chang; Kai Sun; Jing-Yu Fan; Fu-Long Liao; Chuan-She Wang; Jun Zheng; Jing-Yan Han
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Effect of notoginsenoside R1 on hepatic microcirculation disturbance induced by gut ischemia and reperfusion.

Authors:  Wei-Xing Chen; Fang Wang; Yu-Ying Liu; Qing-Jiang Zeng; Kai Sun; Xin Xue; Xiang Li; Ji-Ying Yang; Li-Hua An; Bai-He Hu; Jin-Hui Yang; Chuan-She Wang; Zhi-Xin Li; Lian-Yi Liu; Yan Li; Jun Zheng; Fu-Long Liao; Dong Han; Jing-Yu Fan; Jing-Yan Han
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

3.  Compound Danshen injection improves endotoxin-induced microcirculatory disturbance in rat mesentery.

Authors:  Jing-Yan Han; Yoshinori Horie; Soichiro Miura; Yasutada Akiba; Jun Guo; Dan Li; Jing-Yu Fan; Yu-Ying Liu; Bai-He Hu; Li-Hua An; Xin Chang; Man Xu; De-An Guo; Kai Sun; Ji-Ying Yang; Shu-Ping Fang; Ming-Ji Xian; Masahiro Kizaki; Hiroshi Nagata; Toshifumi Hibi
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

4.  Recommendations on the Clinical Use of Compound Danshen Dripping Pills.

Authors: 
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

5.  MicroRNA-1 and Circulating Microvesicles Mediate the Protective Effects of Dantonic in Acute Myocardial Infarction Rat Models.

Authors:  Tingting Sun; Lihua Zhang; Xinxin Li; Fengfei Chen; Yanchuan Li; Xiaohui Ma; Feng Yu
Journal:  Front Physiol       Date:  2018-09-24       Impact factor: 4.566

6.  Observation of mesenteric microcirculatory disturbance in rat by laser oblique scanning optical microscopy.

Authors:  Yichen Ding; Yu Zhang; Tong Peng; Yiqing Lu; Dayong Jin; Qiushi Ren; Yuying Liu; Jingyan Han; Peng Xi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

8.  Cardiotonic pill attenuates white matter and hippocampal damage via inhibiting microglial activation and downregulating ERK and p38 MAPK signaling in chronic cerebral hypoperfused rat.

Authors:  Ki Mo Lee; Ji Hye Bang; Jung-Soo Han; Bu Yeo Kim; In Sun Lee; Hyung Won Kang; Won Kyung Jeon
Journal:  BMC Complement Altern Med       Date:  2013-11-26       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.